Novartis’ Kisqali gets expanded FDA OK; Mene Pangalos joins Omega Funds
The FDA’s clearance could double Kisqali’s breast cancer market. Elsewhere, Novo is exploring new ways to deliver genetic ...
Vincennes Sun-Commercial4d
FDA Expands Use of Breast Cancer Drug Kisqali
Women with early stage breast cancer may now take Kisquali, a medication already approved for advanced disease, following the ...
pharmaphorum4d
Creative review: The Cannes Lions trends that pharma needs to know about
That’s increasingly where those audiences live so, despite obvious regulatory challenges, it’s rapidly becoming a commercial imperative ... the growth of women’s sports stimulated an ...
Insider Monkey26d
10 Cheap Pharmaceutical Stocks to Buy According to Short Sellers
In pulsed field ablation, we initiated the commercial launch of the VARIPULSE ... As a reminder, the registrational HPTN 084 study of PrEP in women was the first to show 0 infections in ...
FDA expands use of Kisqali to early stage breast cancer patients
Women with early stage breast cancer may now take Kisqali, a medication already approved for advanced disease.
UPI4d
FDA expands use of Kisqali to early stage breast cancer patients
Women with early stage breast cancer may now take Kisqali, a medication already approved for advanced disease, following the U.S. Food and Drug Administration's expanded approval of the treatment ...
FDA expands approval of breast cancer drug Kisqali to earlier-stage patients
The Food and Drug Administration expanded the approval of Kisqali, a drug for metastatic breast cancer, to also treat ...
Medical Xpress4d
FDA expands use of breast cancer drug Kisqali
Women with early stage breast cancer may now take Kisqali, a medication already approved for advanced disease, following the U.S. Food and Drug Administration's expanded approval of the treatment ...
NBC DFW5d
FDA expands approval of breast cancer drug Kisqali to earlier stage patients
The Food and Drug Administration expanded the approval of Kisqali, a drug for metastatic ... The approval means that tens of thousands of women diagnosed with early-stage breast cancer will ...